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Introduction: Children with Down syndrome present with multiple medical problems
in a higher prevalence compared with the general population, which may lead to
hospitalizations.
Methods:Analysis of 560 hospitalizations of 162 children aged 0–16 years with Down syn-
drome at Hadassah Medical Center during the years 1988–2007 compared with data on
children in the general population, hospitalized at the same period. Data was collected from
patient files and statistical data from the Ministry of Health.
Results: Respiratory infections were the leading cause for hospitalization of children with
Down syndrome. The number of hospitalizations of children with Down syndrome com-
pared to the number of all children, who were hospitalized was surprisingly similar to their
proportion in the general population. Eleven children died during their hospitalization (five
heart failure, three sepsis, one respiratory tract infection, and one due to complication after
surgery). Nine of the 11 had a congenital heart anomaly.
Conclusion: Children with Down syndrome can present with complex medical issues and
we support the concept of a multidisciplinary team that has experience and knowledge
to serve as a “one stop shop” for these individuals and their families, with timely visits
in which a comprehensive evaluation is performed, problems attended to and prevention
plans applied. In this way, we may prevent morbidity, hospitalizations, and mortality.
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INTRODUCTION
Down syndrome is the most prevalent genetic disorder in humans
and the most common genetic cause for intellectual disability.
Ninety-six percent of cases are the result of trisomy 21. According
to the Ministry of Health records 6,900 individuals with DS live in
Israel. The annual number of newborns in Israel is today 162,000,
of which 160 have DS. This syndrome may cause multiple congeni-
tal anomalies, e.g., heart malformations, intestinal atresia, cataract,
hearing loss, and hypothyroidism, as well as evolving medical
conditions, e.g., diabetes mellitus, convulsions, and dementia (1–
3). These medical issues need to be observed and treated ade-
quately and continuously in order to prevent deterioration, loss of
functions, hospitalizations, and fatalities.
Hilton et al. (4) in a study on respiratory disorders in chil-
dren with DS found respiratory infections the leading cause for
hospitalizations among 232 children with DS, mainly pneumo-
nia and bronchiolitis, with hospitalizations two to three times
longer than among children without DS. A survey (5) among par-
ents to children with DS found that 88% of their children were
hospitalized at least once, while Bloemers et al. (6) found a cor-
relation between DS and severe respiratory syncytial viral (RSV)
bronchiolitis.
Another study by So et al. (7) followed 200 newborns with
DS and found that 54% were already hospitalized by the age
of 3 years, mainly due to respiratory infections with congeni-
tal heart anomaly as a major risk factor for hospitalization. In
an Israeli study, Megged and Schlesinger (8) reviewed medical
records of all children with DS hospitalized in their center due to
infection with respiratory syncytial virus during a 9 year period
and found 41 hospitalizations of 39 children with DS with a
mean age of 1.3 years and an average length of hospitalization
of 10.9 days. Children with DS were older than healthy con-
trols with respiratory syncytial virus infection and needed longer
hospitalization.
The present study is concerned with the hospitalizations of
children with DS hospitalized at two major medical centers in
Jerusalem during 1997–2008. The morbidity, mortality, duration
of hospitalization, population characteristics are described as well
as compared with the general pediatric population hospitalized at
these centers during the same years.
MATERIALS AND METHODS
This is an analytic retrospective study, based on 560 medical
records of 162 children (age 0–16 years) with Down syndrome
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hospitalized in the Hadassah Medical Center during 1997–2008.
Hadassah Hebrew University Medical Center includes two Univer-
sity Hospitals, Hadassah Ein Kerem and Hadassah Mount Scopus
with a total of 1,000 beds. It is a referral center and a level 1 trauma
center.
Using the computerized system of the hospital’s archives, we
reviewed data from all discharge notes that included the diagnosis
“Down syndrome” or “Trisomy 21,” regarding gender, ethnicity,
age at hospitalization, length of stay, causes of hospitalization,
co-morbidities, complications, or death. The number of hospi-
talizations of children with DS was compared with the number of
hospitalizations of all children at the same period. The study was
approved by the Institutional Review Board.
STATISTICS
In order to compare quantitative variables one sample t -test
was used. Comparing categorical data (e.g., prevalence of co-
morbidities) one sample chi-square test was used. Testing the
relation between two categorical data was done using chi-square
test of Fisher’s exact test. Comparing quantitative variables (e.g.,
average length of stay per male vs. female) was done using t -test
for two independent groups and Mann–Whitney test for abnor-
mal distribution. All tests were bidirectional and a P value of 0.05
or less was considered statistically significant.
RESULTS
During the years 1997–2008 there were 255,764 hospitalizations
of children in the Hadassah Medical Center. Of these 560 (0.22%,
1/457) were children with DS. Our population included a total
of 162 children with DS who had records of 560 hospitaliza-
tion episodes. One hundred sixteen (71.6%) were Jewish and 46
(28.4%) Arab. Twenty-nine percent had one record of hospitaliza-
tion, 22% had two, and 49% had three or more hospitalizations.
There was a male predominance of 62%. The main causes for hos-
pitalization are detailed in Table 1, the causes of hospitalization by
age in Table 2, and the causes of recurrent hospitalizations shown
in Table 3.
Respiratory tract infection was the main cause for the first
recorded hospitalization in 55.6% of cases, and 55.56% in the
second or third hospitalization.
Regarding the medical background of these children, includ-
ing a history of heart anomalies, pulmonary hypertension,
leukemia, gastrointestinal malformation, hearing impairment,
adenoid hypertrophy, and hypothyroidism, we found no statis-
tical significant difference between having any of those med-
ical problems and the main reason of hospitalization. Of all
of the above the leading reason was respiratory tract infec-
tions. There was no correlation between gender and/or eth-
nicity and a different main cause for hospitalization – again,
respiratory infections were the leading cause in all sectors and
genders.
Eleven children with DS died during their hospitalization, five
had a severe heart anomaly and suffered from severe heart failure.
Three died from severe sepsis, one from respiratory tract infection
and failure, and one due to complication after surgery. Nine of the
11 had a congenital heart anomaly.
Table 1 | Main causes for hospitalization.
Cause Number (%) Mean
age in
months
Mean duration
of hospitalization
in days
Respiratory tract infections 222 (39.6) 36.76 7.62
Surgical procedures 125 (22.3) 30.29 9.65
Heart failure 45 (8) 27.52 12.62
Acute gastroenteritis 39 (7) 16.39 6.15
Sepsis 28 (5) 29.02 20.21
Failure to thrive 22 (3.9) 7.56 7.41
Jaundice in neonate 4 (0.7) 0.65 6.25
Urinary tract infections 3 (0.5) 39.33 3
Others 72 (12.9) 55.22 8.14
Total 560 33.76 9.03
Table 2 | Causes of hospitalization by age.
Cause of hospitalization N Mean age (months)
Hyperbilirubinemia 4 0.65
Sepsis 27 29.02
FTT 22 7.57
Respiratory infection 222 36.76
Operation 125 30.29
Cardiac failure 45 27.52
Diarrhea 39 16.39
UTI 3 39.33
Other 72 55.23
Total 559 33.76
Table 3 | Causes of recurrent hospitalizations.
Main frequent reason for hospitalization Total (%)
Sepsis 4.32
FTT 4.32
Respiratory infection 55.56
Operation 19.75
Cardiac failure 3.7
Diarrhea 3.09
Other 9.26
Total 100
DISCUSSION
This study presents the main causes of hospitalizations and re-
hospitalizations of children with Down syndrome aged 0–16 years.
Our study showed that the leading cause for hospitalization was
respiratory infections. A limitation of this study is the fact that it
may not necessarily represent the general DS population in Israel.
However, the male predominance and the prevalence of heart
anomalies in our cohort, which is very similar to that reported
on the DS population suggests that it may not be very different
from the whole DS population in Israel.
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We demonstrated that the duration of hospitalization for a child
with DS who had a respiratory infection was on average 9 days,
whereas sepsis may take as long as 20 days of hospitalization.
As mentioned above during 1997–2008, there were 255,764
hospitalizations of children in the Hadassah Medical Center with
560 (0.22%, 1/457) children with DS. According to information
from the Ministry of Health the birth rate of neonates with DS is
approximately 0.1% or 1 per 1,000. The total population of Israel
is 7.8 million with 900,000 (11.5%) living in the Jerusalem region.
In the years 1995–2003, a total of 1,155 children with DS were
born in Israel, of those 323 (27.96%) in the Jerusalem district,
which is more than double of the expected with regards to the
population size of the Jerusalem district. This is probably due to
the large proportion of ultra orthodox Jewish and Arab popula-
tion in the city, who are not doing prenatal diagnosis. Therefore
the proportion of children with DS, who were hospitalized was
double to its proportion in the general population. In this pop-
ulation, good community services and well monitoring of their
medical condition in an event of acute illness by their physi-
cians is an important aspect. Nevertheless 49% of the children
in our group were hospitalized three or more times. This again
stresses the need for regular follow-up and surveillance of these
children.
We found a strong relationship between DS and hospitaliza-
tions due to respiratory infections and therefore support the need
for RSV, pneumoccocal, and influenza vaccines in this population.
In our study group, there were 11 fatalities, of which nine had
a congenital heart anomaly. Although it is a small group, we may
reasonably estimate that heart anomalies are risk factors for death
in this population.
CONCLUSION
In summary, morbidity of children with Down syndrome causes
hospitalizations, which may be recurrent, frequent, and prolonged.
It should be our goal as medical health providers to prevent or at
least minimize as much as possible the medical problems among
this special population. We support the concept of a multidisci-
plinary team that has experience and knowledge, and serves as
a “one stop shop” for these individuals and their families (9–
11), with timely visits in which a comprehensive evaluation is
done, problems are attended to and prevention plans applied. In
this way, we may prevent morbidity, hospitalizations, and mortal-
ity. This study emphasizes the need for comprehensive vaccina-
tions against respiratory tract pathogens in this risk population,
including anti pneumococcal vaccine, anti influenza vaccine, and
anti RSV immunoglobulins.
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